Michael Mollerus
Lawyers
Filters
Innate Pharma $79 Million U.S. Initial Public Offering of ADS on Nasdaq and Concurrent Private Placement
Davis Polk advised the underwriters in connection with an initial public offering of 8,047,227 American Depositary Shares of Innate Pharma S.A. and a concurrent private placement of 4,452…
Davis Polk Advises Hudson Group on Its Acquisition of Brookstone Airport Stores from Apex Digital
Davis Polk is advising Hudson Group in connection with its acquisition of assets related to the operation of Brookstone stores in U.S. airports from Apex Digital, Inc. Hudson has also…
Davis Polk Advises SS&C on Its Acquisition of Algorithmics Assets from IBM
Davis Polk is advising SS&C Technologies Holdings, Inc. on its acquisition of assets of IBM’s Algorithmics business. The transaction is expected to close in the fourth quarter of 2019,…
Honeywell International Inc. $2.7 Billion Notes Offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Honeywell International Inc. of $600 million aggregate principal amount of its 2.150%…
BR Distribuidora S.A. R$9.6 Billion Secondary Follow-on Offering
Davis Polk advised the respective agents of the Brazilian underwriters in connection with the follow-on offering by Petróleo Brasileiro S.A. — Petrobras of 393,187,500 common shares of BR…
Tax counsel to Pfizer on the combination of its Upjohn business with Mylan
Davis Polk is acting as special tax counsel to Pfizer Inc. on the combination of its off-patent branded and generic established medicines business, Upjohn, with Mylan N.V. Under the terms…
Terrafina $500 Million Notes Offering and Concurrent Tender Offer
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A and Regulation S offering by Terrafina of $500 million aggregate principal amount…
Davis Polk Advises Uniti on Its $345 Million Exchangeable Notes Offering and Related Hedge and Warrant Transactions
Davis Polk advised Uniti Group Inc. (“Uniti Group”) and Uniti Fiber Holdings Inc. (“Uniti Fiber,” and together with Uniti Group, “Uniti”) in connection with a Rule 144A offering of $345…
Stoke Therapeutics, Inc. Initial Public Offering
Davis Polk advised the representatives of the underwriters in connection with the $163.3 million initial public offering of 9,074,776 shares of common stock of Stoke Therapeutics, Inc.,…
Jones Energy, Inc. Restructuring and Emergence from Chapter 11
Davis Polk advised an ad hoc group of holders of the unsecured notes and the first-lien notes of Jones Energy, Inc. in connection with Jones Energy’s comprehensive balance sheet…